Corbus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.About CRBP
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity.
CRBP Key Statistics
Stock Snapshot
As of today, Corbus Pharmaceuticals(CRBP) shares are valued at $10.09. The company's market cap stands at 178.96M, with a P/E ratio of -1.57.
During the trading session on 2026-04-01, Corbus Pharmaceuticals(CRBP) shares reached a daily high of $10.33 and a low of $9.46. At a current price of $10.09, the stock is +6.7% higher than the low and still -2.3% under the high.
Trading volume for Corbus Pharmaceuticals(CRBP) stock has reached 58.98K, versus its average volume of 200.07K.
Over the past 52 weeks, Corbus Pharmaceuticals(CRBP) stock has traded between a high of $20.56 and a low of $4.64.
Over the past 52 weeks, Corbus Pharmaceuticals(CRBP) stock has traded between a high of $20.56 and a low of $4.64.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.